Eicosapentaenoic acid for the prevention of recurrent atrial fibrillation

Annals of Noninvasive Electrocardiology

Volumn 16, Issue 4, 2011, Pages 373-378

  Watanabe, Eiichi ^a   Sobue, Yoshihiro ^a   Sano, Kan ^a   Okuda, Kentarou ^a   Yamamoto, Mayumi ^a   Ozaki, Yukio ^a  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

arrhythmia; dyslipidemia; electrocardiogram; fish oil; inflammation

Indexed keywords

ANTIARRHYTHMIC AGENT; C REACTIVE PROTEIN; EPADEL; ICOSAPENTAENOIC ACID; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFICACY; ELECTROCARDIOGRAPHY MONITORING; FEMALE; HEART ATRIUM FIBRILLATION; HEART PROTECTION; HUMAN; JAPANESE; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RECURRENT DISEASE; SINGLE BLIND PROCEDURE; TREATMENT DURATION;

ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; C-REACTIVE PROTEIN; DRUG THERAPY, COMBINATION; EICOSAPENTAENOIC ACID; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECURRENCE;

EID: 80054814575     PISSN: 1082720X     EISSN: 1542474X     Source Type: Journal    
DOI: 10.1111/j.1542-474X.2011.00465.x     Document Type: Article

References (26)

1. Benjamin EJ, Wolf PA, D'Agostino RB, et al,. Impact of atrial fibrillation on the risk of death: The Framingham Heart Study. Circulation 1998; 98: 946-952. (Pubitemid 28446646)
2. Roy D, Talajic M, Dorian P, et al,. Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators. N Engl J Med 2000; 342: 913-920. (Pubitemid 30177051)
3. Corley SD, Epstein AE, DiMarco JP, et al,. Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study. Circulation 2004; 109: 1509-1513. (Pubitemid 38420179)
4. Mozaffarian D, Psaty BM, Rimm EB, et al,. Fish intake and risk of incident atrial fibrillation. Circulation 2004; 110: 368-373. (Pubitemid 38993844)
5. Frost L, Vestergaard P,. n-3 Fatty acids consumed from fish and risk of atrial fibrillation or flutter: The Danish Diet, Cancer, and Health Study. Am J Clin Nutr 2005; 81: 50-54. (Pubitemid 43073375)
6. Brouwer IA, Heeringa J, Geleijnse JM, et al,. Intake of very long-chain n-3 fatty acids from fish and incidence of atrial fibrillation. The Rotterdam Study. Am Heart J 2006; 151: 857-862.
7. Berry JD, Prineas RJ, van Horn L, et al,. Dietary fish intake and incident atrial fibrillation (from the Women's Health Initiative). Am J Cardiol 2010; 105: 844-848.
8. Mori TA, Beilin LJ,. Omega-3 fatty acids and inflammation. Curr Atheroscler Rep 2004; 6: 461-467. (Pubitemid 39585671)
9. Chobanian AV, Bakris GL, Black HR, et al,. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA 2003; 289: 2560-2572. (Pubitemid 37430158)
10. Yokoyama M, Origasa H,. Effects of eicosapentaenoic acid on cardiovascular events in Japanese patients with hypercholesterolemia: Rationale, design, and baseline characteristics of the Japan EPA Lipid Intervention Study (JELIS). Am Heart J 2003; 146: 613-620. (Pubitemid 37281704)
11. Mozaffarian D, Rimm EB,. Fish intake, contaminants, and human health: Evaluating the risks and the benefits. JAMA 2006; 296: 1885-1899. (Pubitemid 44596197)
12. Kowey PR, Reiffel JA, Ellenbogen KA, et al,. Efficacy and safety of prescription omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation. JAMA 2010; 304: 2363-2372.
13. +current in human atrial myocytes. Cardiovasc Res 2009; 81: 286-293.
14. + exchange currents in HEK293t cells. Biochem Biophys Res Commun 2004; 321: 116-123. (Pubitemid 39060658)
15. da Cunha DN, Hamlin RL, Billman GE, et al,. n-3 (omega-3) polyunsaturated fatty acids prevent acute atrial electrophysiological remodeling. Br J Pharmacol 2007; 150: 281-285. (Pubitemid 46221037)
16. Sakabe M, Shiroshita-Takeshita A, Maguy A, et al,. Omega-3 polyunsaturated fatty acids prevent atrial fibrillation associated with heart failure but not atrial tachycardia remodeling. Circulation 2007; 116: 2101-2109. (Pubitemid 350060347)
17. Sarrazin JF, Comeau G, Daleau P, et al,. Reduced incidence of vagally induced atrial fibrillation and expression levels of connexins by n-3 polyunsaturated fatty acids in dogs. J Am Coll Cardiol 2007; 50: 1505-1512. (Pubitemid 47494587)
18. Laurent G, Moe G, Hu X, et al,. Long chain n-3 polyunsaturated fatty acids reduce atrial vulnerability in a novel canine pacing model. Cardiovasc Res 2008; 77: 89-97. (Pubitemid 351195152)
19. Ramadeen A, Laurent G, dos Santos CC, et al,. n-3 Polyunsaturated fatty acids alter expression of fibrotic and hypertrophic genes in a dog model of atrial cardiomyopathy. Heart Rhythm 2010; 7: 520-528.
20. Mayyas F, Sakurai S, Ram R, et al,. Dietary omega3 fatty acids modulate the substrate for post-operative atrial fibrillation in a canine cardiac surgery model. Cardiovasc Res 2011; 89: 852-861.
21. Chung MK, Martin DO, Sprecher D, et al,. C-reactive protein elevation in patients with atrial arrhythmias: Inflammatory mechanisms and persistence of atrial fibrillation. Circulation 2001; 104: 2886-2891. (Pubitemid 33139098)
22. Watanabe E, Arakawa T, Uchiyama T, et al,. High-sensitivity C-reactive protein is predictive of successful cardioversion for atrial fibrillation and maintenance of sinus rhythm after conversion. Int J Cardiol 2006; 108: 346-353. (Pubitemid 43339801)
23. Heidarsdottir R, Arnar DO, Skuladottir GV, et al,. Does treatment with n-3 polyunsaturated fatty acids prevent atrial fibrillation after open heart surgery? Europace 2010; 12: 356-363.
24. Guidelines for Pharmacotherapy of Atrial Fibrillation (JCS 2008). Circ J 2010; 74: 2479-2500.
25. Fuster V, Ryden LE, Cannom DS, et al,. ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006; 114: e257-354. (Pubitemid 44252297)
26. Camm AJ, Kirchhof P, Lip GY, et al,. Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010; 31: 2369-2429.